Picture of Covalon Technologies logo

COV Covalon Technologies Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Covalon Technologies, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

2019
September 30th
C2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.14-7.820.419-9.25-4.46
Depreciation
Amortisation
Non-Cash Items2.612.6127.20.9992
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital3.08-0.075-1.08-0.083-0.318
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-2.83-4.5327.2-7.31-1.81
Capital Expenditures-1.28-0.206-0.178-1.08-1.32
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-5.810.001-0.1010.239-0.135
Acquisition of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-7.1-0.205-0.279-0.843-1.45
Financing Cash Flow Items-0.41-0.343-0.2930
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14-1.41-8.25-2.19-2.16
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.09-6.0719.4-8.89-5.27